AML (ACUTE MYELOID LEUKEMIA)
Clinical trials for AML (ACUTE MYELOID LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOID LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOID LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for untreated leukemia patients
Disease control Recruiting nowThis study is testing a combination of five drugs (venetoclax, azacitidine, cytarabine, idarubicin, and G-CSF) as a first treatment for adults with acute myeloid leukemia (AML) who are healthy enough for strong chemotherapy. The goal is to see how many patients achieve complete r…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
Double stem cell transplant shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It uses stem cells from a half-matched family donor plus umbilical cord blood, given a few days apart, to help the body accept the new…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
New cell therapy targets tough blood cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can help prevent the …
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for High-Risk leukemia: Post-Transplant pill aims to keep cancer away
Disease control Recruiting nowThis study tests whether a drug called chidamide can help prevent relapse in people with high-risk acute myeloid leukemia (AML) after a stem cell transplant. About 134 adults aged 18-75 who are in remission after transplant will either receive chidamide or be observed. The goal i…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New hope for tough blood cancers: CBX-250 trial opens
Disease control Recruiting nowThis early-stage study tests a new drug called CBX-250 in about 72 people with certain blood cancers (like acute myeloid leukemia) that have returned or not improved with standard therapy. The main goals are to check the drug's safety and find the best dose. Participants receive …
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Mice with human cancer could speed up AML treatment discovery
Knowledge-focused Recruiting nowThis study aims to develop a faster way to test new drug combinations for acute myeloid leukemia (AML). Researchers will take blood and bone marrow samples from 25 AML patients and grow their cancer cells in special mice. They will then test how well standard and new treatments w…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated May 17, 2026 02:44 UTC
-
New study reveals how cancer drug affects other medications
Knowledge-focused Recruiting nowThis study looks at how olutasidenib, a drug for certain cancers with an IDH1 mutation, changes the way the body processes other medications. Researchers will give participants a mix of test drugs before and during olutasidenib treatment to measure differences in drug levels. The…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 02:42 UTC
-
Smartwatches could help doctors personalize blood transfusions for cancer patients
Knowledge-focused Recruiting nowThis study is for 80 adults with blood cancers like MDS or AML who are starting treatment. Researchers will give them a smartwatch to track activity and ask them to fill out surveys about how they feel. The goal is to see how low blood counts affect quality of life and find bette…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated May 14, 2026 12:07 UTC